Scientific Discovery Supported by the Hirshberg Foundation, at UCLA Ductal adenocarcinoma of the pancreas, which comprises 90% of all human pancreatic cancers, is a devastating disease, with overall 5-year survival […]
GenVec Announces Efficacy Update in Phase II/III Clinical Trial
Press Release
GenVec Receives Clearance from FDA for EUS Administration
Press Release
Five Seed Grants Awarded, November, 2007
Hirshberg Foundation for Pancreatic Cancer Research announced the recipients of their annual seed grant program. For the past several years the award has been given to a single researcher, but this […]
Vitamin D May Cut Pancreatic Cancer Risk by Nearly Half
September 12, 2006 – PHILADELPHIA — Consumption of Vitamin D tablets was found to cut the risk of pancreatic cancer nearly in half, according to a study led by researchers at […]
Threshold Pharmaceuticals Completes Enrollment in Phase 3 and Phase 2 Trials for the Treatment of Pancreatic Cancer
Press Release